Skip to main content
Normal View

HSE Expenditure

Dáil Éireann Debate, Tuesday - 23 October 2012

Tuesday, 23 October 2012

Questions (588, 624, 625)

Caoimhghín Ó Caoláin

Question:

588. Deputy Caoimhghín Ó Caoláin asked the Minister for Health the full drugs bill for the Health Service Executive for 2010, 2011 and to date in 2012; if he will provide a breakdown of same by scheme, by patent status and branded generic status [45703/12]

View answer

Pearse Doherty

Question:

624. Deputy Pearse Doherty asked the Minister for Health if he will provide an estimate of the cost of drugs and medication used by the public health service in each of 2010 and 2011 [45962/12]

View answer

Pearse Doherty

Question:

625. Deputy Pearse Doherty asked the Minister for Health if he will provide an estimate of the cost of generic drugs and medication used by the public health service in 2010 and 2011 [45963/12]

View answer

Written answers

I propose to take Questions Nos. 588, 624 and 625 together.

HSE expenditure on drugs and non-drug items (dressings, etc.) under the GMS and community drug schemes for the years 2010 and 2011, including mark ups and dispensing fees for pharmacists and wholesalers, is set out in the following table:

-

2011

2010

Cost of drugs prescribed under the GMS and community drug schemes

€1,851,930,928

€1,910,628,331

Note:

Data source for 2010 - Primary Care Reimbursement Service's Statistical Analysis of Claims and Payments. Data source for 2011: Primary Care Reimbursement Service (unpublished data).

The HSE's Performance Report indicates that expenditure up to July 2012 is approximately €1 billion. Expenditure on generic drugs is estimated to be in the region of €100 million per annum. The outstanding information sought by the Deputies is being collated and will be supplied as soon as possible.

Top
Share